Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, 33014, Tampere, Finland.
Breast Cancer Res Treat. 2010 Nov;124(2):377-86. doi: 10.1007/s10549-010-0808-0. Epub 2010 Feb 25.
Bone morphogenetic proteins (BMP) are extracellular signaling molecules that belong to the transforming growth factor β (TGFβ) superfamily. Bone morphogenetic proteins have diverse roles during development where they regulate proliferation, differentiation, and apoptosis in many different cell types by modulating the transcription of specific target genes. BMPs have also been implicated in both promotion and inhibition of cancer progression. We have recently shown that BMP4 is commonly expressed in breast cancer but its functional significance has not been previously explored. Our data demonstrate that in all nine breast cancer cell lines studied, BMP4 treatment leads to a dramatic growth suppression as a result of the induction of G1 arrest of the cell cycle. At the same time, BMP4 stimulates cell migration and invasion in a subset of these breast cancer cell lines. The BMP4-induced phenotypic changes were mediated through the activation of the canonical SMAD signaling pathway whereas no activation of MAP-kinases ERK1/2 or p38 was detected. Our results thus implicate that BMP4 is an important regulator of key phenotypic characteristics of cancer cells, cell growth, cell migration, and invasion, and that, similar to TGFβ, it possesses both tumor suppressive and oncogenic properties in breast cancer.
骨形态发生蛋白(BMP)是属于转化生长因子 β(TGFβ)超家族的细胞外信号分子。BMP 在发育过程中具有多种作用,通过调节特定靶基因的转录,调节许多不同类型细胞的增殖、分化和凋亡。BMP 还与癌症的促进和抑制进展有关。我们最近表明,BMP4 在乳腺癌中普遍表达,但它的功能意义尚未被探索。我们的数据表明,在所有研究的九种乳腺癌细胞系中,BMP4 处理导致细胞周期 G1 期阻滞,导致细胞生长受到明显抑制。同时,BMP4 刺激这些乳腺癌细胞系中的一部分细胞迁移和侵袭。BMP4 诱导的表型变化是通过激活经典 SMAD 信号通路介导的,而没有检测到 MAP-激酶 ERK1/2 或 p38 的激活。因此,我们的结果表明,BMP4 是癌细胞关键表型特征、细胞生长、细胞迁移和侵袭的重要调节剂,并且与 TGFβ 类似,它在乳腺癌中具有肿瘤抑制和致癌特性。